IGC Pharma Inc (AMEX: IGC) is -11.00% lower on its value in year-to-date trading and has touched a low of $0.25 and a high of $0.50 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IGC stock was last observed hovering at around $0.38 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $0.37, the stock is 16.54% and 19.35% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.06 million and changing -1.60% at the moment leaves the stock 12.84% off its SMA200. IGC registered 11.52% gain for a year compared to 6-month loss of 13.08%. The firm has a 50-day simple moving average (SMA 50) of $0.3144 and a 200-day simple moving average (SMA200) of $0.33245.
The stock witnessed a 21.07% gain in the last 1 month and extending the period to 3 months gives it a 39.29%, and is 18.09% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.24% over the week and 6.43% over the month.
IGC Pharma Inc (IGC) has around 70 employees, a market worth around $31.44M and $1.27M in sales. Profit margin for the company is -560.27%. Distance from 52-week low is 48.40% and -24.76% from its 52-week high. The company has generated returns on investments over the last 12 months (-109.99%).
.
IGC Pharma Inc (IGC) Top Institutional Holders
26.0 institutions hold shares in IGC Pharma Inc (IGC), with institutional investors hold 21.89% of the company’s shares. The shares outstanding are 80.88M, and float is at 57.25M with Short Float at 0.89%. Institutions hold 19.89% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 0.7 million shares valued at $0.31 million. The investor’s holdings represent 1.1961% of the IGC Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 0.65 million shares valued at $0.28 million to account for 1.0965 of the shares outstanding. The other top investors are GEODE CAPITAL MANAGEMENT, LLC which holds 0.43 million shares representing 0.7305% and valued at over $0.19 million, while STATE STREET CORP holds 0.2809 of the shares totaling 0.17 million with a market value of $71710.0.
IGC Pharma Inc (IGC) Insider Activity
The most recent transaction is an insider purchase by Moran James P, the company’s Director. SEC filings show that Moran James P bought 588,235 shares of the company’s common stock on Sep 25 ’24 at a price of $0.34 per share for a total of $0.2 million. Following the purchase, the insider now owns 0.94 million shares.